However, the role of Cx43 varies depending on the type of cancer: in lung cancer, it appeared to prevent cisplatin resistance, whereas in glioblastoma, it may contribute to temozolomide resistance [206,207]. This evidence concerns the gene GJA1 and lung cancer.